CMRX Chimerix | $3.44
-0.6% | 12/30/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 -> $11.00 | N/A | View details for HC Wainwright rating of Chimerix (NASDAQ:CMRX) on 12/30/2024 |
HALO Halozyme Therapeutics | $47.99
-0.3% | 12/30/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $68.00 -> $68.00 | N/A | View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 12/30/2024 |
BBAI BigBear.ai | $4.81
+14.3% | 12/30/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $3.00 -> $7.00 | N/A | View details for HC Wainwright rating of BigBear.ai (NYSE:BBAI) on 12/30/2024 |
NUVL Nuvalent | $77.87
-3.0% | 12/30/2024 | Initiated by | HC Wainwright | - | Buy | $110.00 | N/A | View details for HC Wainwright rating of Nuvalent (NASDAQ:NUVL) on 12/30/2024 |
NAMS NewAmsterdam Pharma | $25.60
-1.0% | 12/30/2024 | Initiated by | HC Wainwright | - | Buy | $48.00 | N/A | View details for HC Wainwright rating of NewAmsterdam Pharma (NASDAQ:NAMS) on 12/30/2024 |
MTVA MetaVia | $1.98
+12.5% | 12/30/2024 | Initiated by | HC Wainwright | - | Buy | $12.00 | N/A | View details for HC Wainwright rating of MetaVia (NASDAQ:MTVA) on 12/30/2024 |
|
EBS Emergent BioSolutions | $9.25
+11.9% | 12/30/2024 | Initiated by | HC Wainwright | - | Buy | $15.00 | N/A | View details for HC Wainwright rating of Emergent BioSolutions (NYSE:EBS) on 12/30/2024 |
ARTV Artiva Biotherapeutics | $10.58
-0.6% | 12/30/2024 | Initiated by | HC Wainwright | - | Buy | $20.00 | N/A | View details for HC Wainwright rating of Artiva Biotherapeutics (NASDAQ:ARTV) on 12/30/2024 |
ARQT Arcutis Biotherapeutics | $14.20
-0.7% | 12/30/2024 | Initiated by | HC Wainwright | - | Buy | $19.00 | N/A | View details for HC Wainwright rating of Arcutis Biotherapeutics (NASDAQ:ARQT) on 12/30/2024 |
GALT Galectin Therapeutics | $1.10
-4.3% | 12/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Neutral | | N/A | View details for HC Wainwright rating of Galectin Therapeutics (NASDAQ:GALT) on 12/27/2024 |
ASMB Assembly Biosciences | $16.03
+5.7% | 12/27/2024 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | | N/A | View details for HC Wainwright rating of Assembly Biosciences (NASDAQ:ASMB) on 12/27/2024 |
PYPD PolyPid | $3.15
+9.0% | 12/26/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $14.00 -> $11.00 | N/A | View details for HC Wainwright rating of PolyPid (NASDAQ:PYPD) on 12/26/2024 |
AVXL Anavex Life Sciences | $11.04
-8.8% | 12/26/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $40.00 -> $42.00 | N/A | View details for HC Wainwright rating of Anavex Life Sciences (NASDAQ:AVXL) on 12/26/2024 |
PVLA Palvella Therapeutics | $12.00
| 12/26/2024 | Initiated by | HC Wainwright | Analyst A. Fein | Buy | $38.00 | N/A | View details for HC Wainwright rating of Palvella Therapeutics (NASDAQ:PVLA) on 12/26/2024 |
RAPT RAPT Therapeutics | $1.62
-4.1% | 12/26/2024 | Upgraded by | HC Wainwright | Analyst R. Selvaraju | Neutral -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of RAPT Therapeutics (NASDAQ:RAPT) on 12/26/2024 |
BTCS BTCS | $2.50
-1.6% | 12/24/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $3.00 -> $5.00 | N/A | View details for HC Wainwright rating of BTCS (NASDAQ:BTCS) on 12/24/2024 |
FPAY FlexShopper | $1.61
+7.3% | 12/24/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.50 -> $2.50 | N/A | View details for HC Wainwright rating of FlexShopper (NASDAQ:FPAY) on 12/24/2024 |
ZURA Zura Bio | $2.55
+2.0% | 12/24/2024 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Neutral -> Neutral | $5.00 -> $5.00 | N/A | View details for HC Wainwright rating of Zura Bio (NASDAQ:ZURA) on 12/24/2024 |
ENTA Enanta Pharmaceuticals | $5.85
-2.7% | 12/24/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $27.00 -> $18.00 | N/A | View details for HC Wainwright rating of Enanta Pharmaceuticals (NASDAQ:ENTA) on 12/24/2024 |
RARE Ultragenyx Pharmaceutical | $42.27
-2.6% | 12/24/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $95.00 -> $95.00 | N/A | View details for HC Wainwright rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 12/24/2024 |
NDA Neptune Digital Assets | C$1.01
-6.5% | 12/23/2024 | Target Raised by | HC Wainwright | - | Buy | C$1.00 -> C$2.00 | N/A | View details for HC Wainwright rating of Neptune Digital Assets (CVE:NDA) on 12/23/2024 |
PBYI Puma Biotechnology | $3.13
+1.6% | 12/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Puma Biotechnology (NASDAQ:PBYI) on 12/23/2024 |
AMTX Aemetis | $2.81
| 12/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $28.00 -> $28.00 | N/A | View details for HC Wainwright rating of Aemetis (NASDAQ:AMTX) on 12/23/2024 |
REE REE Automotive | $9.90
+3.8% | 12/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 -> $15.00 | N/A | View details for HC Wainwright rating of REE Automotive (NASDAQ:REE) on 12/23/2024 |
VYNE VYNE Therapeutics | $3.19
+0.6% | 12/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.75 -> $5.75 | N/A | View details for HC Wainwright rating of VYNE Therapeutics (NASDAQ:VYNE) on 12/23/2024 |
SOUN SoundHound AI | $22.68
-5.3% | 12/23/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $8.00 -> $26.00 | N/A | View details for HC Wainwright rating of SoundHound AI (NASDAQ:SOUN) on 12/23/2024 |
BWAY BrainsWay | $9.22
+1.0% | 12/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 -> $16.00 | N/A | View details for HC Wainwright rating of BrainsWay (NASDAQ:BWAY) on 12/23/2024 |
RMTI Rockwell Medical | $2.05
-4.2% | 12/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Rockwell Medical (NASDAQ:RMTI) on 12/23/2024 |
RYTM Rhythm Pharmaceuticals | $56.34
+1.3% | 12/23/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $69.00 -> $69.00 | N/A | View details for HC Wainwright rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 12/23/2024 |
VNDA Vanda Pharmaceuticals | $4.78
-0.6% | 12/23/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $18.00 -> $18.00 | N/A | View details for HC Wainwright rating of Vanda Pharmaceuticals (NASDAQ:VNDA) on 12/23/2024 |
SMTI Sanara MedTech | $33.19
-0.9% | 12/23/2024 | Initiated by | HC Wainwright | Analyst Y. Chen | Buy | $50.00 | N/A | View details for HC Wainwright rating of Sanara MedTech (NASDAQ:SMTI) on 12/23/2024 |
ENGN enGene | $6.75
+5.1% | 12/23/2024 | Initiated by | HC Wainwright | Analyst A. Maldonado | Buy | $25.00 | N/A | View details for HC Wainwright rating of enGene (NASDAQ:ENGN) on 12/23/2024 |
ACRS Aclaris Therapeutics | $2.48
-9.2% | 12/23/2024 | Upgraded by | HC Wainwright | Analyst R. Selvaraju | Neutral -> Buy | $20.00 -> $20.00 | N/A | View details for HC Wainwright rating of Aclaris Therapeutics (NASDAQ:ACRS) on 12/23/2024 |
PYXS Pyxis Oncology | $1.56
-1.9% | 12/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $5.00 | N/A | View details for HC Wainwright rating of Pyxis Oncology (NASDAQ:PYXS) on 12/20/2024 |
IFRX InflaRx | $2.64
+1.9% | 12/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 -> $8.00 | N/A | View details for HC Wainwright rating of InflaRx (NASDAQ:IFRX) on 12/20/2024 |
ARWR Arrowhead Pharmaceuticals | $18.61
-1.8% | 12/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $80.00 -> $80.00 | N/A | View details for HC Wainwright rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 12/20/2024 |
CYTK Cytokinetics | $47.15
-0.4% | 12/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $120.00 -> $120.00 | N/A | View details for HC Wainwright rating of Cytokinetics (NASDAQ:CYTK) on 12/20/2024 |
LGO Largo | $1.73
+2.1% | 12/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.20 -> $4.20 | N/A | View details for HC Wainwright rating of Largo (NYSE:LGO) on 12/20/2024 |
HUMA Humacyte | $5.09
-7.5% | 12/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $15.00 | N/A | View details for HC Wainwright rating of Humacyte (NASDAQ:HUMA) on 12/20/2024 |
PSNL Personalis | $5.97
+1.7% | 12/20/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $9.00 -> $11.00 | N/A | View details for HC Wainwright rating of Personalis (NASDAQ:PSNL) on 12/20/2024 |
No one’s talking about these Trump trades (Ad) As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid.
Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities.
But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.” Go here to see how you can start accessing these opportunities today |
VRTX Vertex Pharmaceuticals | $399.35
-2.3% | 12/20/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $600.00 -> $535.00 | N/A | View details for HC Wainwright rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 12/20/2024 |
PRTA Prothena | $14.88
-1.7% | 12/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $84.00 -> $48.00 | N/A | View details for HC Wainwright rating of Prothena (NASDAQ:PRTA) on 12/20/2024 |
VERU Veru | $0.64
-6.0% | 12/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 -> $3.00 | N/A | View details for HC Wainwright rating of Veru (NASDAQ:VERU) on 12/20/2024 |
LVTX LAVA Therapeutics | $0.99
-0.3% | 12/20/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $6.00 -> $2.00 | N/A | View details for HC Wainwright rating of LAVA Therapeutics (NASDAQ:LVTX) on 12/20/2024 |
ORKA Oruka Therapeutics | $18.95
-0.3% | 12/20/2024 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $45.00 -> $45.00 | N/A | View details for HC Wainwright rating of Oruka Therapeutics (NASDAQ:ORKA) on 12/20/2024 |
ALMS Alumis | $7.52
-6.7% | 12/20/2024 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $26.00 -> $26.00 | N/A | View details for HC Wainwright rating of Alumis (NASDAQ:ALMS) on 12/20/2024 |
AQST Aquestive Therapeutics | $3.52
| 12/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of Aquestive Therapeutics (NASDAQ:AQST) on 12/20/2024 |
FNV Franco-Nevada | $116.96
-1.4% | 12/20/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $200.00 -> $155.00 | N/A | View details for HC Wainwright rating of Franco-Nevada (NYSE:FNV) on 12/20/2024 |
RNA Avidity Biosciences | $29.18
-3.1% | 12/20/2024 | Initiated by | HC Wainwright | Analyst A. Ghosh | Buy | $72.00 | N/A | View details for HC Wainwright rating of Avidity Biosciences (NASDAQ:RNA) on 12/20/2024 |
AIRJ Montana Technologies | $8.44
-15.0% | 12/20/2024 | Initiated by | HC Wainwright | Analyst A. Dayal | Buy | $12.00 | N/A | View details for HC Wainwright rating of Montana Technologies (NASDAQ:AIRJ) on 12/20/2024 |
CLDX Celldex Therapeutics | $25.12
-1.1% | 12/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $80.00 -> $80.00 | N/A | View details for HC Wainwright rating of Celldex Therapeutics (NASDAQ:CLDX) on 12/19/2024 |
IMNN Imunon | $0.83
+4.0% | 12/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $12.00 | N/A | View details for HC Wainwright rating of Imunon (NASDAQ:IMNN) on 12/19/2024 |
GPCR Structure Therapeutics | $26.63
-8.3% | 12/19/2024 | Reiterated by | HC Wainwright | Analyst A. Ghosh | Buy -> Buy | $80.00 -> $80.00 | N/A | View details for HC Wainwright rating of Structure Therapeutics (NASDAQ:GPCR) on 12/19/2024 |
PTN Palatin Technologies | $1.15
+3.6% | 12/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.00 -> $17.00 | N/A | View details for HC Wainwright rating of Palatin Technologies (NYSEAMERICAN:PTN) on 12/19/2024 |
ACET Adicet Bio | $0.90
-2.8% | 12/19/2024 | Reiterated by | HC Wainwright | Analyst E. White | Neutral -> Neutral | | N/A | View details for HC Wainwright rating of Adicet Bio (NASDAQ:ACET) on 12/19/2024 |
SGMO Sangamo Therapeutics | $2.34
-8.6% | 12/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of Sangamo Therapeutics (NASDAQ:SGMO) on 12/19/2024 |
ARMP Armata Pharmaceuticals | $1.90
-10.0% | 12/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Armata Pharmaceuticals (NYSEAMERICAN:ARMP) on 12/19/2024 |
UROY Uranium Royalty | $2.17
| 12/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.70 -> $7.70 | N/A | View details for HC Wainwright rating of Uranium Royalty (NASDAQ:UROY) on 12/19/2024 |
VSTM Verastem | $3.67
-1.1% | 12/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Verastem (NASDAQ:VSTM) on 12/19/2024 |
SRPT Sarepta Therapeutics | $121.19
-0.3% | 12/19/2024 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Sell -> Sell | $75.00 -> $75.00 | N/A | View details for HC Wainwright rating of Sarepta Therapeutics (NASDAQ:SRPT) on 12/19/2024 |
CGTX Cognition Therapeutics | $0.75
-10.7% | 12/19/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $5.00 -> $6.00 | N/A | View details for HC Wainwright rating of Cognition Therapeutics (NASDAQ:CGTX) on 12/19/2024 |
WRN Western Copper & Gold | $1.04
-1.0% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.25 -> $4.25 | N/A | View details for HC Wainwright rating of Western Copper & Gold (NYSE:WRN) on 12/18/2024 |
VKTX Viking Therapeutics | $39.77
-3.4% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $102.00 -> $102.00 | N/A | View details for HC Wainwright rating of Viking Therapeutics (NASDAQ:VKTX) on 12/18/2024 |
TNYA Tenaya Therapeutics | $1.45
-3.3% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 -> $18.00 | N/A | View details for HC Wainwright rating of Tenaya Therapeutics (NASDAQ:TNYA) on 12/18/2024 |
JOBY Joby Aviation | $8.39
-6.0% | 12/18/2024 | Reiterated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for HC Wainwright rating of Joby Aviation (NYSE:JOBY) on 12/18/2024 |
RICK RCI Hospitality | $57.63
-0.1% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $98.00 -> $98.00 | N/A | View details for HC Wainwright rating of RCI Hospitality (NASDAQ:RICK) on 12/18/2024 |
EXK Endeavour Silver | $3.56
-3.5% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.25 -> $7.25 | N/A | View details for HC Wainwright rating of Endeavour Silver (NYSE:EXK) on 12/18/2024 |
HALO Halozyme Therapeutics | $47.99
-0.3% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $68.00 -> $68.00 | N/A | View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 12/18/2024 |
ECOR electroCore | $16.98
+3.2% | 12/18/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $22.00 -> $25.00 | N/A | View details for HC Wainwright rating of electroCore (NASDAQ:ECOR) on 12/18/2024 |
ALXO ALX Oncology | $1.66
+2.5% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $25.00 -> $25.00 | N/A | View details for HC Wainwright rating of ALX Oncology (NASDAQ:ALXO) on 12/18/2024 |
PDSB PDS Biotechnology | $1.69
-1.2% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $21.00 -> $21.00 | N/A | View details for HC Wainwright rating of PDS Biotechnology (NASDAQ:PDSB) on 12/18/2024 |
KRYS Krystal Biotech | $159.80
+0.3% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $221.00 -> $221.00 | N/A | View details for HC Wainwright rating of Krystal Biotech (NASDAQ:KRYS) on 12/18/2024 |
CADL Candel Therapeutics | $7.95
-10.4% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 -> $19.00 | N/A | View details for HC Wainwright rating of Candel Therapeutics (NASDAQ:CADL) on 12/18/2024 |
CRDL Cardiol Therapeutics | $1.28
-2.3% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for HC Wainwright rating of Cardiol Therapeutics (NASDAQ:CRDL) on 12/18/2024 |
FGEN FibroGen | $0.53
-8.4% | 12/17/2024 | Upgraded by | HC Wainwright | Analyst M. Keller | Strong-Buy | | N/A | View details for HC Wainwright rating of FibroGen (NASDAQ:FGEN) on 12/17/2024 |
HRMY Harmony Biosciences | $34.06
-0.4% | 12/17/2024 | Initiated by | HC Wainwright | Analyst P. Trucchio | Buy | $75.00 | N/A | View details for HC Wainwright rating of Harmony Biosciences (NASDAQ:HRMY) on 12/17/2024 |
MITK Mitek Systems | $11.29
-0.5% | 12/17/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $11.00 -> $13.00 | N/A | View details for HC Wainwright rating of Mitek Systems (NASDAQ:MITK) on 12/17/2024 |
NMG Nouveau Monde Graphite | $1.57
-1.9% | 12/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 -> $3.00 | N/A | View details for HC Wainwright rating of Nouveau Monde Graphite (NYSE:NMG) on 12/17/2024 |
ARCT Arcturus Therapeutics | $16.58
-2.6% | 12/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $63.00 -> $63.00 | N/A | View details for HC Wainwright rating of Arcturus Therapeutics (NASDAQ:ARCT) on 12/17/2024 |
DARE Daré Bioscience | $3.23
-1.2% | 12/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $12.00 | N/A | View details for HC Wainwright rating of Daré Bioscience (NASDAQ:DARE) on 12/17/2024 |
BHVN Biohaven | $35.78
-2.4% | 12/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $59.00 -> $59.00 | N/A | View details for HC Wainwright rating of Biohaven (NYSE:BHVN) on 12/17/2024 |
FENC Fennec Pharmaceuticals | $6.16
-1.0% | 12/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $13.00 -> $13.00 | N/A | View details for HC Wainwright rating of Fennec Pharmaceuticals (NASDAQ:FENC) on 12/17/2024 |
ANNX Annexon | $5.13
-1.2% | 12/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for HC Wainwright rating of Annexon (NASDAQ:ANNX) on 12/17/2024 |
FHTX Foghorn Therapeutics | $4.61
-4.4% | 12/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 -> $13.00 | N/A | View details for HC Wainwright rating of Foghorn Therapeutics (NASDAQ:FHTX) on 12/17/2024 |
PHAR Pharming Group | $9.70
-5.1% | 12/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $37.00 -> $37.00 | N/A | View details for HC Wainwright rating of Pharming Group (NASDAQ:PHAR) on 12/17/2024 |
APRE Aprea Therapeutics | $3.48
+3.3% | 12/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 -> $20.00 | N/A | View details for HC Wainwright rating of Aprea Therapeutics (NASDAQ:APRE) on 12/17/2024 |
CRVO CervoMed | $2.39
-0.4% | 12/17/2024 | Downgraded by | HC Wainwright | Analyst R. Selvaraju | Buy -> Neutral | | N/A | View details for HC Wainwright rating of CervoMed (NASDAQ:CRVO) on 12/17/2024 |
LRMR Larimar Therapeutics | $3.91
-1.3% | 12/16/2024 | Reiterated by | HC Wainwright | Analyst E. White | Buy -> Buy | $15.00 -> $15.00 | N/A | View details for HC Wainwright rating of Larimar Therapeutics (NASDAQ:LRMR) on 12/16/2024 |
VRDN Viridian Therapeutics | $19.54
+0.5% | 12/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $34.00 -> $34.00 | N/A | View details for HC Wainwright rating of Viridian Therapeutics (NASDAQ:VRDN) on 12/16/2024 |
ACHR Archer Aviation | $10.06
-10.0% | 12/16/2024 | Reiterated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $12.50 -> $12.50 | N/A | View details for HC Wainwright rating of Archer Aviation (NYSE:ACHR) on 12/16/2024 |
$20k in extra income? (Ad) My friend Alex Reid just might have created my favorite strategy right now.
You see, Alex has figured out how to cut-the-corner so to speak, and be one of the laziest traders possible….
While still showing his traders how to target big money.
This past year, his LIVE “lazy trade” alerts have delivered impressive results—and that’s only a fraction of the opportunities he’s shared.
And that’s just just a quarter of the total trade alerts he’s sent out.
The true total profit potential his beta-testers have had the chance to target is far larger than $20k.  Alex recorded a special video training where he reveals exactly how much. |
BCYC Bicycle Therapeutics | $14.13
-2.9% | 12/16/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $55.00 -> $33.00 | N/A | View details for HC Wainwright rating of Bicycle Therapeutics (NASDAQ:BCYC) on 12/16/2024 |
ASRT Assertio | $0.88
-1.3% | 12/16/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $4.00 -> $4.00 | N/A | View details for HC Wainwright rating of Assertio (NASDAQ:ASRT) on 12/16/2024 |
SPRB Spruce Biosciences | $0.43
-2.7% | 12/16/2024 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | | N/A | View details for HC Wainwright rating of Spruce Biosciences (NASDAQ:SPRB) on 12/16/2024 |
NMRA Neumora Therapeutics | $11.06
-2.4% | 12/16/2024 | Reiterated by | HC Wainwright | Analyst D. Tsao | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for HC Wainwright rating of Neumora Therapeutics (NASDAQ:NMRA) on 12/16/2024 |
PYPD PolyPid | $3.15
+9.0% | 12/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $14.00 -> $14.00 | N/A | View details for HC Wainwright rating of PolyPid (NASDAQ:PYPD) on 12/16/2024 |
NBIX Neurocrine Biosciences | $137.06
-1.7% | 12/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $190.00 -> $190.00 | N/A | View details for HC Wainwright rating of Neurocrine Biosciences (NASDAQ:NBIX) on 12/16/2024 |
BBIO BridgeBio Pharma | $27.32
-2.4% | 12/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $49.00 -> $49.00 | N/A | View details for HC Wainwright rating of BridgeBio Pharma (NASDAQ:BBIO) on 12/16/2024 |
CARM Carisma Therapeutics | $0.44
-4.2% | 12/16/2024 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Neutral | | N/A | View details for HC Wainwright rating of Carisma Therapeutics (NASDAQ:CARM) on 12/16/2024 |
CKPT Checkpoint Therapeutics | $3.35
-4.0% | 12/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 -> $20.00 | N/A | View details for HC Wainwright rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 12/16/2024 |
BMEA Biomea Fusion | $3.88
-3.0% | 12/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $40.00 -> $40.00 | N/A | View details for HC Wainwright rating of Biomea Fusion (NASDAQ:BMEA) on 12/16/2024 |
DGHI Digihost Technology | $1.63
-10.9% | 12/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.50 -> $2.50 | N/A | View details for HC Wainwright rating of Digihost Technology (NASDAQ:DGHI) on 12/16/2024 |
BNTC Benitec Biopharma | $12.51
+4.3% | 12/16/2024 | Initiated by | HC Wainwright | Analyst P. Trucchio | Buy | $28.00 | N/A | View details for HC Wainwright rating of Benitec Biopharma (NASDAQ:BNTC) on 12/16/2024 |
DEF Defiance Silver | C$0.19
-5.1% | 12/12/2024 | Upgraded by | HC Wainwright | Analyst K. Dede | Strong-Buy | | N/A | View details for HC Wainwright rating of Defiance Silver (CVE:DEF) on 12/12/2024 |
DEFTF DeFi Technologies | $2.68
-5.6% | 12/12/2024 | Upgraded by | HC Wainwright | Analyst K. Dede | Strong-Buy | | N/A | View details for HC Wainwright rating of DeFi Technologies (OTC:DEFTF) on 12/12/2024 |
XOMA XOMA | $26.09
-0.8% | 12/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $123.00 -> $123.00 | N/A | View details for HC Wainwright rating of XOMA (NASDAQ:XOMA) on 12/13/2024 |
NYXH Nyxoah | $8.00
| 12/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.00 -> $17.00 | N/A | View details for HC Wainwright rating of Nyxoah (NASDAQ:NYXH) on 12/13/2024 |
ABSI Absci | $2.65
-4.3% | 12/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Absci (NASDAQ:ABSI) on 12/13/2024 |
ELVA Electrovaya | $2.54
+3.7% | 12/13/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $16.00 -> $10.00 | N/A | View details for HC Wainwright rating of Electrovaya (NASDAQ:ELVA) on 12/13/2024 |
ITOS iTeos Therapeutics | $7.29
-0.4% | 12/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $21.00 -> $21.00 | N/A | View details for HC Wainwright rating of iTeos Therapeutics (NASDAQ:ITOS) on 12/13/2024 |
ELEV Elevation Oncology | $0.57
-4.0% | 12/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 -> $6.00 | N/A | View details for HC Wainwright rating of Elevation Oncology (NASDAQ:ELEV) on 12/13/2024 |
KROS Keros Therapeutics | $15.64
-4.8% | 12/13/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $100.00 -> $47.00 | N/A | View details for HC Wainwright rating of Keros Therapeutics (NASDAQ:KROS) on 12/13/2024 |
TRVI Trevi Therapeutics | $4.10
-4.0% | 12/12/2024 | Target Raised by | HC Wainwright | Analyst O. Livnat | Buy -> Buy | $6.00 -> $7.50 | N/A | View details for HC Wainwright rating of Trevi Therapeutics (NASDAQ:TRVI) on 12/12/2024 |
ESPR Esperion Therapeutics | $2.15
-5.7% | 12/12/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 -> $16.00 | N/A | View details for HC Wainwright rating of Esperion Therapeutics (NASDAQ:ESPR) on 12/12/2024 |
ATOS Atossa Therapeutics | $0.97
-0.7% | 12/12/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Atossa Therapeutics (NASDAQ:ATOS) on 12/12/2024 |
PRAX Praxis Precision Medicines | $76.26
-1.0% | 12/12/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $120.00 -> $120.00 | N/A | View details for HC Wainwright rating of Praxis Precision Medicines (NASDAQ:PRAX) on 12/12/2024 |
XENE Xenon Pharmaceuticals | $38.53
-0.8% | 12/12/2024 | Reiterated by | HC Wainwright | Analyst D. Tsao | Buy -> Buy | $53.00 -> $53.00 | N/A | View details for HC Wainwright rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 12/12/2024 |
SLDB Solid Biosciences | $4.07
-4.0% | 12/12/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 -> $16.00 | N/A | View details for HC Wainwright rating of Solid Biosciences (NASDAQ:SLDB) on 12/12/2024 |
IRD Opus Genetics | $1.12
-5.1% | 12/12/2024 | Reiterated by | HC Wainwright | Analyst M. Caufield | Buy -> Buy | $8.00 -> $8.00 | N/A | View details for HC Wainwright rating of Opus Genetics (NASDAQ:IRD) on 12/12/2024 |
PHAT Phathom Pharmaceuticals | $8.00
-2.2% | 12/12/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $28.00 -> $28.00 | N/A | View details for HC Wainwright rating of Phathom Pharmaceuticals (NASDAQ:PHAT) on 12/12/2024 |
BLCO Bausch + Lomb | $17.79
-1.0% | 12/12/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $23.00 -> $23.00 | N/A | View details for HC Wainwright rating of Bausch + Lomb (NYSE:BLCO) on 12/12/2024 |
BCTX BriaCell Therapeutics | $0.57
+2.8% | 12/12/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 -> $15.00 | N/A | View details for HC Wainwright rating of BriaCell Therapeutics (NASDAQ:BCTX) on 12/12/2024 |
PRQR ProQR Therapeutics | $2.65
-5.0% | 12/12/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of ProQR Therapeutics (NASDAQ:PRQR) on 12/12/2024 |
IPA ImmunoPrecise Antibodies | $0.41
-0.2% | 12/11/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $9.00 -> $7.00 | N/A | View details for HC Wainwright rating of ImmunoPrecise Antibodies (NASDAQ:IPA) on 12/11/2024 |
ADCT ADC Therapeutics | $1.90
-6.4% | 12/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | | N/A | View details for HC Wainwright rating of ADC Therapeutics (NYSE:ADCT) on 12/11/2024 |
VGZ Vista Gold | $0.54
-3.0% | 12/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.75 -> $2.75 | N/A | View details for HC Wainwright rating of Vista Gold (NYSE:VGZ) on 12/11/2024 |
ANAB AnaptysBio | $13.22
+1.4% | 12/11/2024 | Downgraded by | HC Wainwright | Analyst E. Bodnar | Buy -> Neutral | $52.00 -> $19.00 | N/A | View details for HC Wainwright rating of AnaptysBio (NASDAQ:ANAB) on 12/11/2024 |
PHAR Pharming Group | $9.70
-5.1% | 12/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $37.00 -> $37.00 | N/A | View details for HC Wainwright rating of Pharming Group (NASDAQ:PHAR) on 12/11/2024 |
RDW Redwire | $17.65
+3.1% | 12/11/2024 | Reiterated by | HC Wainwright | Analyst S. Buck | Buy -> Buy | $18.00 -> $18.00 | N/A | View details for HC Wainwright rating of Redwire (NYSE:RDW) on 12/11/2024 |
SUUN SolarBank | $1.96
-4.4% | 12/11/2024 | Initiated by | HC Wainwright | Analyst A. Dayal | Buy | $6.00 | N/A | View details for HC Wainwright rating of SolarBank (NASDAQ:SUUN) on 12/11/2024 |
UUUU Energy Fuels | $5.11
-1.7% | 12/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 -> $11.00 | N/A | View details for HC Wainwright rating of Energy Fuels (NYSE:UUUU) on 12/11/2024 |
SLRN Acelyrin | $3.08
-5.2% | 12/11/2024 | Reiterated by | HC Wainwright | Analyst E. Bodnar | Neutral -> Neutral | $8.00 -> $8.00 | N/A | View details for HC Wainwright rating of Acelyrin (NASDAQ:SLRN) on 12/11/2024 |
IMNN Imunon | $0.83
+4.0% | 12/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $12.00 | N/A | View details for HC Wainwright rating of Imunon (NASDAQ:IMNN) on 12/11/2024 |
OLMA Olema Pharmaceuticals | $5.61
-8.8% | 12/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for HC Wainwright rating of Olema Pharmaceuticals (NASDAQ:OLMA) on 12/11/2024 |
CMRX Chimerix | $3.44
-0.6% | 12/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 -> $11.00 | N/A | View details for HC Wainwright rating of Chimerix (NASDAQ:CMRX) on 12/11/2024 |
LGND Ligand Pharmaceuticals | $105.76
-3.1% | 12/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | | N/A | View details for HC Wainwright rating of Ligand Pharmaceuticals (NASDAQ:LGND) on 12/11/2024 |
LSTA Lisata Therapeutics | $2.94
-2.6% | 12/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 -> $15.00 | N/A | View details for HC Wainwright rating of Lisata Therapeutics (NASDAQ:LSTA) on 12/11/2024 |
COGT Cogent Biosciences | $7.71
-0.4% | 12/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | | N/A | View details for HC Wainwright rating of Cogent Biosciences (NASDAQ:COGT) on 12/11/2024 |
YMAB Y-mAbs Therapeutics | $7.76
-3.0% | 12/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | | N/A | View details for HC Wainwright rating of Y-mAbs Therapeutics (NASDAQ:YMAB) on 12/11/2024 |
NRIX Nurix Therapeutics | $18.64
-2.5% | 12/11/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $30.00 -> $35.00 | N/A | View details for HC Wainwright rating of Nurix Therapeutics (NASDAQ:NRIX) on 12/11/2024 |
TRML Tourmaline Bio | $20.08
-2.9% | 12/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $49.00 -> $49.00 | N/A | View details for HC Wainwright rating of Tourmaline Bio (NASDAQ:TRML) on 12/11/2024 |
$20k in extra income? (Ad) My friend Alex Reid just might have created my favorite strategy right now.
You see, Alex has figured out how to cut-the-corner so to speak, and be one of the laziest traders possible….
While still showing his traders how to target big money.
This past year, his LIVE “lazy trade” alerts have delivered impressive results—and that’s only a fraction of the opportunities he’s shared.
And that’s just just a quarter of the total trade alerts he’s sent out.
The true total profit potential his beta-testers have had the chance to target is far larger than $20k. Alex recorded a special video training where he reveals exactly how much. |
ARVN Arvinas | $19.00
| 12/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $87.00 -> $87.00 | N/A | View details for HC Wainwright rating of Arvinas (NASDAQ:ARVN) on 12/11/2024 |
TCRX TScan Therapeutics | $3.00
-2.0% | 12/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 -> $15.00 | N/A | View details for HC Wainwright rating of TScan Therapeutics (NASDAQ:TCRX) on 12/11/2024 |
ACXP Acurx Pharmaceuticals | $0.85
-4.6% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $12.00 | N/A | View details for HC Wainwright rating of Acurx Pharmaceuticals (NASDAQ:ACXP) on 12/10/2024 |
ANGO AngioDynamics | $9.05
+1.6% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $14.00 -> $14.00 | N/A | View details for HC Wainwright rating of AngioDynamics (NASDAQ:ANGO) on 12/10/2024 |
QURE uniQure | $17.22
-1.6% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $25.00 -> $25.00 | N/A | View details for HC Wainwright rating of uniQure (NASDAQ:QURE) on 12/10/2024 |
VOR Vor Biopharma | $1.19
-6.3% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.50 -> $17.50 | N/A | View details for HC Wainwright rating of Vor Biopharma (NYSE:VOR) on 12/10/2024 |
NVAX Novavax | $7.93
-4.2% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $19.00 -> $19.00 | N/A | View details for HC Wainwright rating of Novavax (NASDAQ:NVAX) on 12/10/2024 |
ATXS Astria Therapeutics | $8.88
-3.0% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 -> $16.00 | N/A | View details for HC Wainwright rating of Astria Therapeutics (NASDAQ:ATXS) on 12/10/2024 |
ATYR Atyr PHARMA | $3.51
-6.1% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $35.00 -> $35.00 | N/A | View details for HC Wainwright rating of Atyr PHARMA (NASDAQ:ATYR) on 12/10/2024 |
CRIS Curis | $3.14
-3.4% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 -> $20.00 | N/A | View details for HC Wainwright rating of Curis (NASDAQ:CRIS) on 12/10/2024 |
SGMO Sangamo Therapeutics | $2.34
-8.6% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of Sangamo Therapeutics (NASDAQ:SGMO) on 12/10/2024 |
NKTR Nektar Therapeutics | $0.94
-0.5% | 12/10/2024 | Initiated by | HC Wainwright | Analyst A. He | Buy | $6.50 | N/A | View details for HC Wainwright rating of Nektar Therapeutics (NASDAQ:NKTR) on 12/10/2024 |
UAMY United States Antimony | $1.80
-6.3% | 12/10/2024 | Initiated by | HC Wainwright | Analyst H. Ihle | Buy | $2.50 | N/A | View details for HC Wainwright rating of United States Antimony (NYSE:UAMY) on 12/10/2024 |
XPL Solitario Resources | $0.60
-0.5% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $1.20 -> $1.20 | N/A | View details for HC Wainwright rating of Solitario Resources (NYSEAMERICAN:XPL) on 12/10/2024 |
SNDX Syndax Pharmaceuticals | $12.52
-2.0% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $51.00 -> $51.00 | N/A | View details for HC Wainwright rating of Syndax Pharmaceuticals (NASDAQ:SNDX) on 12/10/2024 |
APTO Aptose Biosciences | $0.24
-2.0% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.00 -> $2.00 | N/A | View details for HC Wainwright rating of Aptose Biosciences (NASDAQ:APTO) on 12/10/2024 |
BMEA Biomea Fusion | $3.88
-3.0% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $40.00 -> $40.00 | N/A | View details for HC Wainwright rating of Biomea Fusion (NASDAQ:BMEA) on 12/10/2024 |
RIGL Rigel Pharmaceuticals | $16.47
-0.2% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $57.00 -> $57.00 | N/A | View details for HC Wainwright rating of Rigel Pharmaceuticals (NASDAQ:RIGL) on 12/10/2024 |
KRYS Krystal Biotech | $159.80
+0.3% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $221.00 -> $221.00 | N/A | View details for HC Wainwright rating of Krystal Biotech (NASDAQ:KRYS) on 12/10/2024 |
GERN Geron | $3.40
+1.5% | 12/10/2024 | Reiterated by | HC Wainwright | Analyst E. Bodnar | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for HC Wainwright rating of Geron (NASDAQ:GERN) on 12/10/2024 |
ACLX Arcellx | $78.35
-0.9% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $115.00 -> $115.00 | N/A | View details for HC Wainwright rating of Arcellx (NASDAQ:ACLX) on 12/10/2024 |
AFMD Affimed | $1.24
-3.9% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of Affimed (NASDAQ:AFMD) on 12/10/2024 |
MGX Metagenomi | $3.52
-5.9% | 12/10/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $7.00 -> $14.00 | N/A | View details for HC Wainwright rating of Metagenomi (NASDAQ:MGX) on 12/10/2024 |
LEGN Legend Biotech | $32.77
+0.9% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $73.00 -> $73.00 | N/A | View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 12/10/2024 |
PTGX Protagonist Therapeutics | $38.51
-1.2% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 -> $50.00 | N/A | View details for HC Wainwright rating of Protagonist Therapeutics (NASDAQ:PTGX) on 12/10/2024 |
BEAM Beam Therapeutics | $25.27
-5.0% | 12/9/2024 | Reiterated by | HC Wainwright | Analyst P. Trucchio | Buy -> Buy | $80.00 -> $80.00 | N/A | View details for HC Wainwright rating of Beam Therapeutics (NASDAQ:BEAM) on 12/9/2024 |
SLN Silence Therapeutics | $6.91
-2.7% | 12/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $75.00 -> $75.00 | N/A | View details for HC Wainwright rating of Silence Therapeutics (NASDAQ:SLN) on 12/9/2024 |
FUFU BitFuFu | $5.02
-3.3% | 12/9/2024 | Reiterated by | HC Wainwright | Analyst K. Dede | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of BitFuFu (NASDAQ:FUFU) on 12/9/2024 |
UEC Uranium Energy | $6.87
-2.0% | 12/9/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $10.25 -> $11.00 | N/A | View details for HC Wainwright rating of Uranium Energy (NYSEAMERICAN:UEC) on 12/9/2024 |
IPHA Innate Pharma | $1.95
-7.6% | 12/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.50 -> $11.50 | N/A | View details for HC Wainwright rating of Innate Pharma (NASDAQ:IPHA) on 12/9/2024 |
IRON Disc Medicine | $61.60
-3.9% | 12/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $118.00 -> $118.00 | N/A | View details for HC Wainwright rating of Disc Medicine (NASDAQ:IRON) on 12/9/2024 |
CGON CG Oncology | $28.50
-5.1% | 12/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $75.00 -> $75.00 | N/A | View details for HC Wainwright rating of CG Oncology (NASDAQ:CGON) on 12/6/2024 |
ARQQ Arqit Quantum | $43.32
+1.5% | 12/6/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $22.00 -> $27.00 | N/A | View details for HC Wainwright rating of Arqit Quantum (NASDAQ:ARQQ) on 12/6/2024 |
KALV KalVista Pharmaceuticals | $8.39
-1.6% | 12/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 -> $20.00 | N/A | View details for HC Wainwright rating of KalVista Pharmaceuticals (NASDAQ:KALV) on 12/6/2024 |
TARA Protara Therapeutics | $5.28
-4.2% | 12/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $23.00 -> $23.00 | N/A | View details for HC Wainwright rating of Protara Therapeutics (NASDAQ:TARA) on 12/6/2024 |
ZYXI Zynex | $7.94
-3.3% | 12/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.00 -> $17.00 | N/A | View details for HC Wainwright rating of Zynex (NASDAQ:ZYXI) on 12/6/2024 |
BHST BioHarvest Sciences | $5.91
-3.9% | 12/6/2024 | Initiated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $14.00 -> $14.00 | N/A | View details for HC Wainwright rating of BioHarvest Sciences (NASDAQ:BHST) on 12/6/2024 |
BCAX Bicara Therapeutics | $17.00
-7.0% | 12/6/2024 | Initiated by | HC Wainwright | Analyst R. Burns | Buy | $42.00 | N/A | View details for HC Wainwright rating of Bicara Therapeutics (NASDAQ:BCAX) on 12/6/2024 |
AGEN Agenus | $2.69
-2.2% | 12/5/2024 | Reiterated by | HC Wainwright | Analyst E. Bodnar | Neutral -> Neutral | | N/A | View details for HC Wainwright rating of Agenus (NASDAQ:AGEN) on 12/5/2024 |
BTCM BIT Mining | $2.64
-5.4% | 12/5/2024 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | | N/A | View details for HC Wainwright rating of BIT Mining (NYSE:BTCM) on 12/5/2024 |
GLDG GoldMining | $0.80
+2.4% | 12/5/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $5.25 -> $5.50 | N/A | View details for HC Wainwright rating of GoldMining (NYSEAMERICAN:GLDG) on 12/5/2024 |
CRVO CervoMed | $2.39
-0.4% | 12/5/2024 | Initiated by | HC Wainwright | Analyst R. Selvaraju | Buy | $42.00 | N/A | View details for HC Wainwright rating of CervoMed (NASDAQ:CRVO) on 12/5/2024 |
EYPT EyePoint Pharmaceuticals | $7.02
-2.5% | 12/5/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $22.00 -> $22.00 | N/A | View details for HC Wainwright rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 12/5/2024 |
AMLX Amylyx Pharmaceuticals | $3.84
-0.8% | 12/5/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $12.00 | N/A | View details for HC Wainwright rating of Amylyx Pharmaceuticals (NASDAQ:AMLX) on 12/5/2024 |
TRVI Trevi Therapeutics | $4.10
-4.0% | 12/4/2024 | Reiterated by | HC Wainwright | Analyst O. Livnat | Buy -> Buy | | N/A | View details for HC Wainwright rating of Trevi Therapeutics (NASDAQ:TRVI) on 12/4/2024 |
LCTX Lineage Cell Therapeutics | $0.50
-0.2% | 12/4/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $7.00 -> $9.00 | N/A | View details for HC Wainwright rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 12/4/2024 |
CKPT Checkpoint Therapeutics | $3.35
-4.0% | 12/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 -> $20.00 | N/A | View details for HC Wainwright rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 12/4/2024 |
PCRX Pacira BioSciences | $18.94
-3.6% | 12/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $39.00 -> $39.00 | N/A | View details for HC Wainwright rating of Pacira BioSciences (NASDAQ:PCRX) on 12/4/2024 |
GPCR Structure Therapeutics | $26.63
-8.3% | 12/4/2024 | Initiated by | HC Wainwright | Analyst A. Ghosh | Buy | $80.00 | N/A | View details for HC Wainwright rating of Structure Therapeutics (NASDAQ:GPCR) on 12/4/2024 |
CHRS Coherus BioSciences | $1.50
+0.7% | 12/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Coherus BioSciences (NASDAQ:CHRS) on 12/4/2024 |
$20k in extra income? (Ad) My friend Alex Reid just might have created my favorite strategy right now.
You see, Alex has figured out how to cut-the-corner so to speak, and be one of the laziest traders possible….
While still showing his traders how to target big money.
This past year, his LIVE “lazy trade” alerts have delivered impressive results—and that’s only a fraction of the opportunities he’s shared.
And that’s just just a quarter of the total trade alerts he’s sent out.
The true total profit potential his beta-testers have had the chance to target is far larger than $20k. Alex recorded a special video training where he reveals exactly how much. |
RNAC Cartesian Therapeutics | $18.76
-5.2% | 12/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $41.00 -> $45.00 | N/A | View details for HC Wainwright rating of Cartesian Therapeutics (NASDAQ:RNAC) on 12/4/2024 |
OVID Ovid Therapeutics | $0.96
-1.4% | 12/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 -> $3.00 | N/A | View details for HC Wainwright rating of Ovid Therapeutics (NASDAQ:OVID) on 12/4/2024 |
RYTM Rhythm Pharmaceuticals | $56.34
+1.3% | 12/4/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $69.00 -> $69.00 | N/A | View details for HC Wainwright rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 12/4/2024 |
TERN Terns Pharmaceuticals | $5.53
-4.2% | 12/4/2024 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | $7.50 -> $7.50 | N/A | View details for HC Wainwright rating of Terns Pharmaceuticals (NASDAQ:TERN) on 12/4/2024 |
RLAY Relay Therapeutics | $4.18
-4.1% | 12/4/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $20.00 -> $16.00 | N/A | View details for HC Wainwright rating of Relay Therapeutics (NASDAQ:RLAY) on 12/4/2024 |
RVMD Revolution Medicines | $43.17
-2.4% | 12/4/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $64.00 -> $72.00 | N/A | View details for HC Wainwright rating of Revolution Medicines (NASDAQ:RVMD) on 12/4/2024 |
MARA MARA | $17.29
-6.2% | 12/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $28.00 -> $28.00 | N/A | View details for HC Wainwright rating of MARA (NASDAQ:MARA) on 12/4/2024 |
APTO Aptose Biosciences | $0.24
-2.0% | 12/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.00 -> $2.00 | N/A | View details for HC Wainwright rating of Aptose Biosciences (NASDAQ:APTO) on 12/3/2024 |
HIVE HIVE Digital Technologies | $2.91
-2.0% | 12/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 -> $8.00 | N/A | View details for HC Wainwright rating of HIVE Digital Technologies (NASDAQ:HIVE) on 12/3/2024 |
ARWR Arrowhead Pharmaceuticals | $18.61
-1.8% | 12/3/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $60.00 -> $80.00 | N/A | View details for HC Wainwright rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 12/3/2024 |
FEMY Femasys | $1.10
-2.7% | 12/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $12.00 | N/A | View details for HC Wainwright rating of Femasys (NASDAQ:FEMY) on 12/3/2024 |
ATYR Atyr PHARMA | $3.51
-6.1% | 12/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $35.00 -> $35.00 | N/A | View details for HC Wainwright rating of Atyr PHARMA (NASDAQ:ATYR) on 12/3/2024 |
CLSK CleanSpark | $9.51
-2.8% | 12/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $27.00 -> $27.00 | N/A | View details for HC Wainwright rating of CleanSpark (NASDAQ:CLSK) on 12/3/2024 |
TRX TRX Gold | $0.30
-1.0% | 12/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $1.40 -> $1.50 | N/A | View details for HC Wainwright rating of TRX Gold (NYSE:TRX) on 12/3/2024 |
RLYB Rallybio | $0.93
+1.7% | 12/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 -> $5.00 | N/A | View details for HC Wainwright rating of Rallybio (NASDAQ:RLYB) on 12/3/2024 |
OCUL Ocular Therapeutix | $8.35
-1.1% | 12/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 -> $15.00 | N/A | View details for HC Wainwright rating of Ocular Therapeutix (NASDAQ:OCUL) on 12/3/2024 |
SRPT Sarepta Therapeutics | $121.19
-0.3% | 12/3/2024 | Target Lowered by | HC Wainwright | Analyst M. Kapoor | Sell -> Sell | $80.00 -> $75.00 | N/A | View details for HC Wainwright rating of Sarepta Therapeutics (NASDAQ:SRPT) on 12/3/2024 |
ESPR Esperion Therapeutics | $2.15
-5.7% | 12/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 -> $16.00 | N/A | View details for HC Wainwright rating of Esperion Therapeutics (NASDAQ:ESPR) on 12/3/2024 |
BCTX BriaCell Therapeutics | $0.57
+2.8% | 12/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 -> $15.00 | N/A | View details for HC Wainwright rating of BriaCell Therapeutics (NASDAQ:BCTX) on 12/3/2024 |
JANX Janux Therapeutics | $52.50
-3.0% | 12/3/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $63.00 -> $70.00 | N/A | View details for HC Wainwright rating of Janux Therapeutics (NASDAQ:JANX) on 12/3/2024 |
NVCR NovoCure | $30.08
-2.0% | 12/2/2024 | Reiterated by | HC Wainwright | Analyst E. Bodnar | Buy -> Buy | $30.00 -> $38.00 | N/A | View details for HC Wainwright rating of NovoCure (NASDAQ:NVCR) on 12/2/2024 |
XOMA XOMA | $26.09
-0.8% | 12/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $117.00 -> $123.00 | N/A | View details for HC Wainwright rating of XOMA (NASDAQ:XOMA) on 12/2/2024 |
CYTK Cytokinetics | $47.15
-0.4% | 12/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $120.00 -> $120.00 | N/A | View details for HC Wainwright rating of Cytokinetics (NASDAQ:CYTK) on 12/2/2024 |
EXK Endeavour Silver | $3.56
-3.5% | 12/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.25 -> $7.25 | N/A | View details for HC Wainwright rating of Endeavour Silver (NYSE:EXK) on 12/2/2024 |
DGHI Digihost Technology | $1.63
-10.9% | 12/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.50 -> $2.50 | N/A | View details for HC Wainwright rating of Digihost Technology (NASDAQ:DGHI) on 12/2/2024 |
SLNO Soleno Therapeutics | $45.30
+1.1% | 12/2/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $70.00 -> $70.00 | N/A | View details for HC Wainwright rating of Soleno Therapeutics (NASDAQ:SLNO) on 12/2/2024 |
KZR Kezar Life Sciences | $6.82
+2.7% | 12/2/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Neutral -> Neutral | | N/A | View details for HC Wainwright rating of Kezar Life Sciences (NASDAQ:KZR) on 12/2/2024 |
SPRO Spero Therapeutics | $1.02
-1.0% | 12/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 -> $5.00 | N/A | View details for HC Wainwright rating of Spero Therapeutics (NASDAQ:SPRO) on 12/2/2024 |
MRUS Merus | $41.89
-0.4% | 12/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $85.00 -> $85.00 | N/A | View details for HC Wainwright rating of Merus (NASDAQ:MRUS) on 12/2/2024 |
LEXX Lexaria Bioscience | $2.20
-3.9% | 12/2/2024 | Reiterated by | HC Wainwright | Analyst Y. Chen | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of Lexaria Bioscience (NASDAQ:LEXX) on 12/2/2024 |
CLGN CollPlant Biotechnologies | $3.63
+1.7% | 11/29/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 -> $11.00 | N/A | View details for HC Wainwright rating of CollPlant Biotechnologies (NASDAQ:CLGN) on 11/29/2024 |
SBEV Splash Beverage Group | $0.18
+1.1% | 11/29/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $1.00 -> $0.50 | N/A | View details for HC Wainwright rating of Splash Beverage Group (NYSEAMERICAN:SBEV) on 11/29/2024 |
ALEC Alector | $1.72
-3.4% | 11/29/2024 | Target Lowered by | HC Wainwright | - | Buy | $35.00 -> $7.00 | N/A | View details for HC Wainwright rating of Alector (NASDAQ:ALEC) on 11/29/2024 |
AGEN Agenus | $2.69
-2.2% | 11/29/2024 | Reiterated by | HC Wainwright | Analyst E. Bodnar | Neutral -> Neutral | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Agenus (NASDAQ:AGEN) on 11/29/2024 |
OTLK Outlook Therapeutics | $1.86
-7.5% | 11/29/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for HC Wainwright rating of Outlook Therapeutics (NASDAQ:OTLK) on 11/29/2024 |
ESPR Esperion Therapeutics | $2.15
-5.7% | 11/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 -> $16.00 | N/A | View details for HC Wainwright rating of Esperion Therapeutics (NASDAQ:ESPR) on 11/27/2024 |
FEMY Femasys | $1.10
-2.7% | 11/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $12.00 | N/A | View details for HC Wainwright rating of Femasys (NASDAQ:FEMY) on 11/27/2024 |
MDWD MediWound | $17.91
+1.2% | 11/27/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $28.00 -> $25.00 | N/A | View details for HC Wainwright rating of MediWound (NASDAQ:MDWD) on 11/27/2024 |
SANA Sana Biotechnology | $1.61
| 11/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 -> $8.00 | N/A | View details for HC Wainwright rating of Sana Biotechnology (NASDAQ:SANA) on 11/27/2024 |
CGTX Cognition Therapeutics | $0.75
-10.7% | 11/27/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $5.00 -> $5.00 | N/A | View details for HC Wainwright rating of Cognition Therapeutics (NASDAQ:CGTX) on 11/27/2024 |
AVXL Anavex Life Sciences | $11.04
-8.8% | 11/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $40.00 -> $40.00 | N/A | View details for HC Wainwright rating of Anavex Life Sciences (NASDAQ:AVXL) on 11/27/2024 |
NNE Nano Nuclear Energy | $24.83
-7.8% | 11/27/2024 | Reiterated by | HC Wainwright | Analyst S. Joshi | Buy -> Buy | $50.00 -> $50.00 | N/A | View details for HC Wainwright rating of Nano Nuclear Energy (NASDAQ:NNE) on 11/27/2024 |
IREN Iris Energy | $9.94
-7.2% | 11/27/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $13.00 -> $16.00 | N/A | View details for HC Wainwright rating of Iris Energy (NASDAQ:IREN) on 11/27/2024 |
ELBM Electra Battery Materials | $0.56
+15.9% | 11/27/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $1.40 -> $1.30 | N/A | View details for HC Wainwright rating of Electra Battery Materials (NASDAQ:ELBM) on 11/27/2024 |
VKTX Viking Therapeutics | $39.77
-3.4% | 11/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $102.00 -> $102.00 | N/A | View details for HC Wainwright rating of Viking Therapeutics (NASDAQ:VKTX) on 11/26/2024 |
PSTX Poseida Therapeutics | $9.48
+0.6% | 11/26/2024 | Reiterated by | HC Wainwright | Analyst A. He | Buy -> Neutral | $20.00 -> $9.00 | N/A | View details for HC Wainwright rating of Poseida Therapeutics (NASDAQ:PSTX) on 11/26/2024 |
BHVN Biohaven | $35.78
-2.4% | 11/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $59.00 -> $59.00 | N/A | View details for HC Wainwright rating of Biohaven (NYSE:BHVN) on 11/26/2024 |
SRRK Scholar Rock | $42.91
-3.5% | 11/26/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $40.00 -> $50.00 | N/A | View details for HC Wainwright rating of Scholar Rock (NASDAQ:SRRK) on 11/26/2024 |
INAB IN8bio | $0.27
-0.4% | 11/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | N/A | View details for HC Wainwright rating of IN8bio (NASDAQ:INAB) on 11/26/2024 |
ETON Eton Pharmaceuticals | $13.03
-0.2% | 11/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 -> $15.00 | N/A | View details for HC Wainwright rating of Eton Pharmaceuticals (NASDAQ:ETON) on 11/26/2024 |
RDW Redwire | $17.65
+3.1% | 11/26/2024 | Initiated by | HC Wainwright | Analyst S. Buck | Buy | $18.00 | N/A | View details for HC Wainwright rating of Redwire (NYSE:RDW) on 11/26/2024 |
SAVA Cassava Sciences | $2.40
-4.0% | 11/26/2024 | Downgraded by | HC Wainwright | Analyst V. Bernardino | Buy -> Neutral | $116.00 | N/A | View details for HC Wainwright rating of Cassava Sciences (NASDAQ:SAVA) on 11/26/2024 |
TNYA Tenaya Therapeutics | $1.45
-3.3% | 11/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 -> $18.00 | N/A | View details for HC Wainwright rating of Tenaya Therapeutics (NASDAQ:TNYA) on 11/25/2024 |
BLRX BioLineRx | $0.21
-4.6% | 11/25/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $21.00 -> $9.00 | N/A | View details for HC Wainwright rating of BioLineRx (NASDAQ:BLRX) on 11/25/2024 |
PTN Palatin Technologies | $1.15
+3.6% | 11/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.00 -> $17.00 | N/A | View details for HC Wainwright rating of Palatin Technologies (NYSEAMERICAN:PTN) on 11/25/2024 |
RMTI Rockwell Medical | $2.05
-4.2% | 11/25/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $9.00 -> $7.00 | N/A | View details for HC Wainwright rating of Rockwell Medical (NASDAQ:RMTI) on 11/25/2024 |
NRXP NRx Pharmaceuticals | $1.53
+1.3% | 11/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $19.00 -> $19.00 | N/A | View details for HC Wainwright rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 11/25/2024 |
LGVN Longeveron | $1.77
+1.1% | 11/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of Longeveron (NASDAQ:LGVN) on 11/25/2024 |
RAPT RAPT Therapeutics | $1.62
-4.1% | 11/25/2024 | Reiterated by | HC Wainwright | - | Neutral | | N/A | View details for HC Wainwright rating of RAPT Therapeutics (NASDAQ:RAPT) on 11/25/2024 |
AXSM Axsome Therapeutics | $84.78
-2.2% | 11/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $180.00 -> $180.00 | N/A | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 11/25/2024 |
